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Available online 27 November 2015Background: Despite long-standing calls to disseminate evidence-based treatments for generalized anxiety
(GAD),modest progress has beenmade in the study of how such treatments should be implemented. The prima-
ry objective of this study was to test three competing strategies on how to implement a cognitive behavioral
treatment (CBT) for out-patients with GAD (i.e., comparison of one compensation vs. two capitalizationmodels).
Methods: For our three-arm, single-blinded, randomized controlled trial (implementation of CBT for GAD [IMPLE-
MENT]), we recruited adults with GAD using advertisements in high-circulation newspapers to participate in a
14-session cognitive behavioral treatment (Mastery of your Anxiety and Worry, MAW-packet). We randomly
assigned eligible patients using a full randomization procedure (1:1:1) to three different conditions of implemen-
tation: adherence priming (compensation model), which had a systematized focus on patients' individual GAD
symptoms and how to compensate for these symptoms within the MAW-packet, and resource priming and sup-
portive resource priming (capitalization model), which had systematized focuses on patients' strengths and abil-
ities and how these strengths can be capitalized within the same packet. In the intention-to-treat population an
outcome composite of primary and secondary symptoms-related self-report questionnaires was analyzed based
on a hierarchical linear growth model from intake to 6-month follow-up assessment. This trial is registered at
ClinicalTrials.gov (identiﬁer: NCT02039193) and is closed to new participants.
Findings: From June 2012 to Nov. 2014, from 411 participants that were screened, 57 eligible participants were
recruited and randomly assigned to three conditions. Forty-nine patients (86%) provided outcome data at
post-assessment (14% dropout rate). All three conditions showed a highly signiﬁcant reduction of symptoms
over time. However, compared with the adherence priming condition, both resource priming conditions indicat-
ed faster symptom reduction. The observer ratings of a sub-sample of recorded videos (n=100) showed that the
therapists in the resource priming conditions conducted more strength-oriented interventions in comparison
with the adherence priming condition. No patients died or attempted suicide.
Interpretation: To our knowledge, this is the ﬁrst trial that focuses on capitalization and compensation models
during the implementation of one prescriptive treatment packet for GAD. We have shown that GAD related
symptoms were signiﬁcantly faster reduced by the resource priming conditions, although the limitations of
our study included a well-educated population. If replicated, our results suggest that therapists who implement
a mental health treatment for GAD might proﬁt from a systematized focus on capitalization models.
Funding: Swiss Science National Foundation (SNSF-Nr. PZ00P1_136937/1) awarded to CF.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Evidence-based treatment
Cognitive behavioral therapy
Randomized controlled trial
Implementation strategies1. Introduction
In European countries, the lifetimeprevalence of generalized anxiety
disorder (GAD) varies from 5 to 10% (Lieb et al., 2005). Uncontrollableent of Psychology, Fabrikstr. 8,
Flückiger).
. This is an open access article underworrying as a primary symptom of GAD leads to a maladaptive cogni-
tive strategy to avoid experiencing anxiety (Borkovec et al., 2004) and
emotional states in general (Roemer et al., 2005). Individuals with
GAD show deﬁcits in detecting and regulating emotional states, which
may accelerate a positive feedback circuit between general stress symp-
toms andpathological worrying (Mennin et al., 2009). Finally, experien-
tial avoidance may lead to a restriction in proactive behaviors asthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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than pursuing activities that are consistent with their personal values
(Michelson et al., 2011).
Psychological treatment that intends to be fully therapeutic con-
ducted by trained professionals (bona ﬁde psychotherapy) is an effec-
tive treatment for GAD compared to no treatment and treatment as
usual (Hanrahan et al., 2013; Cuijers et al., 2014) but also ismore gener-
ally an effective treatment for individuals who suffer from any type of
anxiety and/or depression (Flückiger et al., 2014). There are a number
of treatment protocols for cognitive behavioral therapy (CBT) that in-
clude interventions such as psycho education, relaxation techniques,
cognitive restructuring of (meta-) cognitions, (imagery-) exposure,
and in vivo confrontation that primarily reference standard techniques
to correct and compensate for GAD symptoms (Barlow et al., 1992;
Zinbarg et al., 2006). In spite of the empirical evidence of the overall ef-
ﬁcacy of the protocols, there is a systematic lack of knowledge regarding
how therapists should implement these overall protocols and how they
can create productive levels of competent adherence to treatment pro-
tocols (Webb et al., 2010; Owen & Hilsenroth, 2014). From a broader
perspective, psychotherapy dialogues could be observed as highly inter-
active and responsive treatments throughwhich therapists and patients
work together to achieve well-speciﬁed treatment goals that consider
the patient's entire living environment (Norcross, 2011; Wampold &
Imel, 2014). Patients are likely not uniformly skilled, and therapists
might respond to these skills differentially. Pre-existing and/or immedi-
ately activated strengths and deﬁcits in targeted domains could be used
in individualizing treatment either by building new behaviors against
relative deﬁcits (i.e., compensation model) or by building upon relative
strengths in the target areas (i.e., capitalizationmodel). According to the
compensationmodel, treatments will bemore successful in so far as the
therapists target the patient's disorder-relevant individual deﬁcits and
vulnerabilities. In contrast, the capitalization model would lead one to
expect treatments to be more successful insofar as the therapist targets
the patient's relative strengths and resources (Cheavens et al., 2012;
Flückiger & Grosse, 2008). Even the separation into compensation and
capitalization models is probably a false dichotomy, as therapists often
simultaneously respond to the participants' targeted weaknesses as
well as strengths. Indeed, there is a broad tradition in balancing capital-
ization as well as compensation strategies in many psychotherapeutic
orientations (Scheel et al., 2013). However, during the sessions,
therapists performing such treatments might have a particular pull
into one or the other model in general (Gassmann & Grawe, 2006)
and also more speciﬁcally in GAD (Flückiger et al., 2013). According to
Rosenhan's lasting posit helpers might have to actively construct their
clinical realities not only on insane but also on sane perspectives inde-
pendently of the underlying treatment orientation (Rosenhan, 1984).
Rather than creating increasing numbers of new overall treatment
packets, an additional approach to investigating clinical research de-
signs may be to increase the understanding of already effective psycho-
therapies. The present study experimentally examined three ways of
conducting a CBT protocol and their relation to treatment efﬁcacy and
therapist competence.
1.1. Aims of the Trial
This trial investigates three different ways of how to implement a
bonaﬁde psychotherapy based on a cognitive behavioral therapy proto-
col using peer dyad supervision (primings). The participants are
randomly assigned to three priming conditions: (a) adherence priming
(compensation model), (b) resource priming (capitalization model) or
(c) supportive resource priming (capitalization model). The main re-
search questions are as follows: Are the different priming conditions
related to differences in the efﬁcacy of GADoutcomes, general outcomes
and dropout rates? More speciﬁcally, we expect that resource priming
in particular fosters therapist skills and ﬂexibility in in-session
strengths-orientation that might lead to better treatment outcomes.2. Methods
2.1. Study Design
This study is a randomized controlled trial with three active treat-
ment arms. This trial was conducted at the psychotherapy outpatient
clinic in the Department of Psychology at the University of Zürich,
Switzerland. Fig. 1 depicts three treatment conditions (adherence
priming, resource priming, and supportive resource priming) at four as-
sessments (times: intake, intermediate, post, follow-up). This study
protocol was approved by the Ethical Committee of Canton Zurich
(KEK 2011-0475) and overseen by the Ethical Committee of the Philo-
sophical Faculty of the University of Zurich (PhiF-EK_20.1.2012). The
trial was registered at ClinicalTrials.gov (identiﬁer: NCT02039193)
(Flückiger, 2014).
2.2. Participants
2.2.1. Patient Inclusion/Exclusion Criteria
Participants were included in the study if they (a) fulﬁlled the diag-
nostic criteria for GAD based on the structured interview for DSM,
(b) were 18 years of age or older, (c) had sufﬁcient knowledge of Ger-
man and (d) agreed to the informed consent. Participants were exclud-
ed for the following reasons: (a) they had a score of 2 or higher on the
suicide item of the Beck Depression Inventory and/or were found to
have active suicidal plans during the diagnostic screening interview,
(b) they were currently taking a psychotic or bipolar disorder medica-
tion, or (c) they were currently receiving treatment from a professional
psychotherapist. Prescribed medications for anxiety or depressive dis-
orders did not exclude participants from the study, if the dosage had
remained constant for at least one month. The presence of a comorbid-
ity did not result in exclusion from the study if GAD was in the fore-
ground according to the severity rating of the Diagnostic Interview for
DSM diagnoses.
2.2.2. Recruitment
Participants were recruited by means of advertisements in high-
circulation newspapers delivered for free through the Swiss public
transport system. Individuals interested in participating in the study
contacted the study ofﬁce via SMS, e-mail or phone. Positively screened
patients were invited for an intake assessment that used a standardized
interview to determine whether they would be included or excluded.
Participants who were not screened positively were informed of more
appropriate treatments via a phone call or, if requested, face-to-face
contact.
2.2.3. Randomization and Treatment Allocation
After meeting the inclusion criteria, patients were randomly
assigned to one of the three conditions (adherence priming, resource
priming, or supportive resource priming). Treatment allocation was
performed using an online application for full randomization. The allo-
cation concealment was conducted by an independent research assis-
tant. Because all patients were treated using the same CBT protocol,
patients were blinded to their treatment allocation and were not in-
formed about the randomization procedure.
2.2.4. Therapists
Thirteen graduated psychologists with at least 2 years post-graduate
training were recruited from local psychotherapy-training centers that
provided up to 600 h of weekend workshops, including practice intro-
ductions of general therapist skills, cognitive behavioral interventions,
process experiential approaches, and interpersonal approaches in sin-
gle, couple, and group settings. The therapist recruitment was focused
on learning how to conduct the “original” MAW-packet (Zinbarg et al.,
2006; Craske & Barlow, 2006) attracted by an initial 16-hour workshop
presented by the (co-)developer of this cognitive behavioral treatment
Fig. 1. Trial proﬁle.
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ence as study therapists in a prior randomized controlled trial
(ClinicalTrials.gov identiﬁer: NCT01012856). To clarify formal study
questions, the therapists had 1-hour study meetings in small groups
on a monthly basis. These study meetings were conducted for all three
priming conditions together. To emphasize the external validity of the
implementation study, CBT-supervisorswere self-selected by each ther-
apist. All therapists had individualized CBT-supervisions on a 14-day
basis, which is included in their regular postgraduate training protocol
(within the 200 hour requirement to obtain a psychotherapy license
in Switzerland). This supervision was based on a list of approximately
30 accredited CBT-supervisors for postgraduate CBT-trainings.
The assignment of a priming condition to a therapist was conducted
by a joint face-to-face meeting at the very beginning of the study. To re-
spect and coordinate the therapists' preferences (i.e., preferences in
terms of working days and time schedules), the therapists ﬁrst selected
their priming partners and second, they selected a priming condition.
Six groups were made (ﬁve groups with two therapists, one group
with three therapists) and each group had to choose a priming condi-
tion (two groups per condition). Five groups had a preference to a spe-
ciﬁc condition. Only one group had none and was assigned to the
adherence priming condition. In an anonymous retrospective evalua-
tion, all therapists answered the following dichotomous question with
no: “In retrospect, I would prefer to have selected another priming
condition.”
2.3. GAD Treatment Protocol
2.3.1. Mastery of Your Anxiety and Worry Guidelines (MAW-Packet)
The MAW-packet encompasses CBT interventions introduced by
Craske and Barlow (Zinbarg et al., 2006; Craske & Barlow, 2006). This in-
ternationally well-known standard CBT packet for GAD typically consists
of psycho-education on generalized anxiety disorder, relaxation training
(RT), cognitive restructuring (CR) and in vivo situational exposure for pa-
tientswith overt behavioral avoidance. Furthermore, imagery exposure asaGAD-speciﬁc formof in sensu exposurewas applied to reduce subtle ex-
periential avoidance behaviors. Themanualized therapy followed a treat-
ment format of 14 50-minute sessions and a booster session after 6
months (15 sessions in total) based on theMAW-workbook that was de-
livered for every patient. TheMAW-workshopwas focused on how to ap-
propriately adapt the duration and timing of the various standard CBT
interventions to the patients' individual behaviors. At the start of every
therapy, the interviewerwho runs the structured interview for DSMsum-
marized the results of the intake assessments in a two-page case vignette
to facilitate the exchange of information between the intake assessment
and the therapists that conducted the MAW-packet.
2.3.2. Peer Dyadic Supervision (Priming)
To systematically investigate various strategies of how to implement
a standard CBT protocol, all therapists were tutored in peer dyads. On
days of sessions 1 to 5, the therapists were required to contact their
peer partner face-to-face or on the phone to discuss the upcoming ses-
sion in a 5- to 10-minute brief conversation based on a standardized
style-sheet (primings; for a comparable procedure, see Flückiger and
Grosse Holtforth (2008). The primings operationalize different models
on how to involve the patient into the treatment. There were three
priming conditions:
(1) Adherence priming (compensation model): Immediately before
sessions 1 to 5, a therapist conducted a 5-minute conversation
with the tutoring partner about how to implement the disorder-
speciﬁc interventions that were described in the treatment proto-
col. These communications were focused on patient individual
GAD symptoms and any related comorbidities andhow those indi-
vidual sufferings could be adequately compensated for in the pre-
scriptive treatment protocol based on a standardized style-sheet
(see online Appendix). These style-sheets were ﬁlled out by the
therapist prior to theﬁrst therapy session using all of the intake as-
sessment data, including the video recordings of the structured in-
terview for DSM. Based on the patients' individual sufferings,
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forward strategy of how therapists can involve patients in the
treatment protocol (Whisman, 2008).
(2) Resource priming (capitalization model): Immediately before ses-
sions 1 to 5, a therapist conducted a 5-minute conversation about
the potential strengths and abilities of the patient and how these
immediately activated strengths could be capitalized to conduct
the treatment protocol based on a standardized style-sheet (see
Appendix) (Flückiger et al., 2010). These style-sheets were ﬁlled
out by the therapist prior to the ﬁrst therapy session using all of
the intake assessment data, including the video-recordings of the
structured interview for DSM. Resource priming intended to
operationalize an explicit matching strategy of how therapists re-
spond to patients' strengths and weaknesses to involve patients
in the treatment protocol. According to the therapist-guide of the
MAW-manual, every therapy session should include basic capital-
ization strategies such as an emphasis on positive changes during
the past week or reinforcement of progress during the sessions
(Zinbarg et al., 2006).
(3) Supportive resource priming (capitalization model): The support-
ive resource priming condition used the very same style-sheet and
formof peer dyads as the resource priming condition. The only dif-
ference in this condition was a slightly higher ﬂexibility in the
treatment protocol. More speciﬁcally, the therapists in consulta-
tionwith their patients were allowed to invite a helpful signiﬁcant
person from the patient's entourage (such as a partner or best
friend) to participate to sessions 1 (introduction of the GAD-
rationale) and 7 (after intermediate assessment). In addition the
therapists tried to ﬁnd ways; this helpful person could support
the patient in their treatment plan (capitalization of supportive
others) (Zinbarg et al., 2007). In case the patient or the supportive
other person did not consent to direct therapy participation (in 4
cases), therapists were encouraged to ﬁnd indirect ways for pa-
tients to involve the signiﬁcant other to support the patient in
their treatment plan.
2.4. Measures
2.4.1. Structured Clinical Interview for DSM
At intake, the GAD diagnosis and its core symptomatology were
identiﬁed by trained interviewers according to the structured interview
section for GAD [DIPS] (Margraf et al., 1991). Further mental disorders
were assessed using the face-to-face diagnostic interview for DSM-IV
[SKID-I] (Wittchen et al., 1997) by trained and supervised interns with
at least a Bachelor degree in Clinical Psychology. These interns were
not enrolled as therapists. Patients were only included in the study if
three evaluations (self-evaluation, phone screening, structured inter-
view) came to a common agreement for a GAD diagnosis. Reliabilities
were not assessed for the present study.
2.4.2. Outcomes
All outcome measures are taken at intake, between weeks 6 and 7
(intermediate assessment), at week 14 (post-assessment), and at the
6-month follow-up (±2 weeks) based on self-report Likert-scales.
Disorder-speciﬁc (primary) outcomes: The Beck Anxiety Inventory
[BAI] (Beck et al., 1988) is a 21-itemmeasure for general anxiety symp-
toms (α=0.92 in the present sample). The Penn StateWorry Question-
naire [PSWQ] (Meyer et al., 1990) is a 16-itemmeasure of the frequency
and intensity of worry. It has considerable internal consistency (α=
0.86 in the present sample). Secondary outcomes: The Beck Depression
Inventory II [BDI-II] (Beck et al., 1996) is a 21-itemmeasure for depres-
sive symptoms (α=0.92 in the present sample). The 9-item short ver-
sion of the SymptomCheck List [SCL-9] (Klaghofer & Brähler, 2001) is an
index for general severity (α= 0.86 in the present sample). The shortversion of the Resource Self-Report Questionnaire [RES] (Troesken &
Grawe, 2004) measures various domains of individual and interperson-
al strengths (α= 0.92 in the present sample). All the primary and sec-
ondary outcome measures were highly intercorrelated (0.74 N r N 0.47,
p b 0.001 see Appendix II) and a principal component factor analysis ex-
tracted one factor that explained 67.5% of the total variance. For the pur-
poses of the present study report, we therefore included a standardized
composite measure (“outcome composite”) that takes all the 5 primary
and secondary symptom-related self-report measures into account
(α= 0.73 in the present sample).
2.4.3. Cognitive Therapy Scale (CTS-G)
The adapted German version of the cognitive therapy scale is a Likert
scale observer-rating that assesses therapist competencies for cognitive
behavioral therapy (Weck et al., 2010). The CTS-G is composed of 14
items covering a session-structuring scale (e.g., agenda setting, focus on
key cognitions or behaviors) and a general therapeutic competence
scale (e.g., interpersonal effectiveness, use of feedback) applied at 10-
minute intervals during the sessions and aggregated to an overall ses-
sion mean. The CTS-G had considerable reliability (Kruskal γ N 0.78 for
single items; α= 0.88 and 0.80, respectively, for the two scales in the
present sample based on a subsample of 15 randomly selected indepen-
dently evaluated sessions). For the purposes of the study, we analyzed
the item that operationalizes strengths-orientation (i.e., “resource acti-
vation”) aswell as the two scales. Observerswere twomaster's students
in clinical psychology who participated in the initial MAW workshop.
For the observer-basedmeasure, a sub-sample of the ﬁrst 25 completed
therapies was video-analyzed in sessions 2, 5, 8 and 11 and randomly
assigned to oneof the two reviewers (a total of 100 sessions; 32 sessions
in the adherence priming condition, 32 sessions in the resource priming
condition and 36 sessions in the supportive priming condition). Raters
were blinded to the priming conditions.
2.5. Statistical Analyses
Our target sample size was 57 patients, split equally between the
three conditions. Within the pretest–posttest-control group design,
the reported effect sizes (ES Δ) are based on the mean pre-post change
in the treatment group minus the mean pre-post change in the control
group, divided by the pooled pretest standard deviations that can be
interpreted as a Cohens d (Morris, 2008). Based on the grant precondi-
tions, we intended to conduct maximally 60 therapies (20 participants
in each condition) between June 2012 and November 2014. As in
prior psychotherapy trials,we expected a dropout rate of approximately
20% at post-assessment. Assuming an Alpha-error of 5%, a power of 80%
and a correlation coefﬁcient for the repeated assessments of r = .50,
such a sample size is able to detect moderate efﬁcacy differences. How-
ever, because such datawere not previously generatedwithin compara-
ble designs in GAD, there was no rigorous means of estimating required
sample size. Now that these data have been collected sample size ap-
proximations are possible for future studies.
Based on the intent-to-treat sample, efﬁcacy differences were ana-
lyzed using hierarchical linear models consisting of repeated assess-
ments at Level 1 and patients at Level 2 (and therapists at Level 3).
Because the intercept-only models indicated marginal therapist vari-
ance at Level 3, we conducted 2-level growth models that included
Level 1 and Level 2. Restricted maximum likelihood models were ﬁt
(yIJ = β00 + β01 AdPr + β02 RePr + β10 ∗ Time + β11 ∗ Time ∗
AdPr + β12 ∗ Time ∗ AdPr + β20 ∗ Time2 + β21 ∗ Time2 ∗ AdPr + β12 ∗
Time ∗ AdPr + r0j + r1j + etj). Whereas, Time and Time2 indicate the
linear growth (β10) and quadratic growth (β20) of symptom reduction
over the 4 assessment times (intake, intermediate, post, 6-month
follow-up). AdPr and RePr represent dummy codings for adherence
priming (AdPr) and resource priming (RePr) at intake (β01, β02), for lin-
ear growth (β11, β12) aswell as for quadratic growth (β21, β22). Further-
more r0j and r1j are the error-terms for intercept and linear slope at
167C. Flückiger et al. / EBioMedicine 3 (2016) 163–171Level 2 and etj is the error term at Level 1. The CTS-G observer-ratings of
the above-mentioned 100 sessions were analyzed within a traditional
repeated MANOVA design (3 conditions [adherence priming, resource
priming, supportive resource priming] by 4 repeated sessions [sessions
2, 5, 8, 11] by 3 CTS-G scales [resource activation, session-structuring
competence, general therapeutic competence]).
3. Results
Between June 2012 and November 2014, with the last assessments
completed in May 2015, 411 self-selected interested people were
screened via phone call and 125 participants were interviewed, of
whom 57 were eligible. The 57 eligible participants gave informed con-
sent andwere randomly assigned to one of the three conditions (19 par-
ticipants in each condition, Fig. 1). The number of attended sessions per
subjectwas 13.4 (SD=2.2). Fifty-one (89.5%) participants attended the
full allocated intervention of 14 sessions, and 49 (86.0%) participants
completed post-assessments (2 participants who had attended the 14
sessions decided not to participate to the post-assessment). From the
57 subjects that started the treatment, the adherence priming group
had a higher rate of missing post-assessments (5 patients, 26.3%) in
comparison with the other two conditions (1 patient, 5.3%/2 patients,
10.5%; X2[2] = 3.8, p = 0.08). However, this trend disappeared at the
follow-up assessmentwith 45 participants (with overall 12 participants
[21.5%] who missed follow-up assessments).
Comparable to other psychotherapy studies with GAD patients, all
three groups showed a high number of comorbidities and the mean
age was approximately 40 years (see Table 1). In comparison with the
general Swiss population, there was a slight tendency toward a higher
percentage of graduate occupations and bilingual people from an inter-
national background; this might be due to a research-oriented popula-
tion of out-patients that indicated interest in participating in a
university-based clinical trial. The majority of participants were female,Table 1
Baseline characteristics of patients and therapists.
All enrolled
subjects
Adherence
priming
Resource
priming
Supportive
resource
priming
Patients
n 57 19 19 19
Age (SD) 43.9 (12.1) 42.9 (10.5) 42.5 (13.1) 46.3
(12.9)
Female/male (%) 43/14 (25) 12/7 (37) 18/1 (5) 13/6 (32)
Comorbidities
At least one further
diagnosis (%)
30 (53) 7 (37) 12 (63) 11 (58)
Anxiety disorder (%) 20 (35) 6 (32) 7 (37) 7 (37)
Depression (%) 10 (18) 1 (5) 6 (32) 3 (16)
Further treatments
On psychotropic
medication (%)
15 (26) 4 (21) 7 (37) 4 (21)
Past psychotherapy (%) 24 (42) 7 (37) 6 (32) 11 (58)
Socio cultural aspects
Graduate occupation (%) 19 (33) 8 (42) 5 (26) 6 (32)
Swiss-German as ﬁrst
language (%)
34 (60) 11 (58) 13 (68) 10 (53)
On persistent close
partnership (%)
34 (60) 11 (58) 12 (63) 11 (58)
Therapists
n 13 4 4 5
Age (SD) 30.2 (3.7) 31.8 (3.9) 29.0 (2.2) 29.8 (5.1)
female/male 13/0 4/0 4/0 5/0
PhD degree (%) 8 (62) 3 (75) 3 (75) 2 (40)
Prior experience in an
RCT (%)
9 (69) 3 (75) 3 (75) 3 (60)
Recent appointment in
an in-patient clinic (%)
5 (38) 2 (50) 2 (50) 1 (20)
Sessions of supervision
per therapy (SD)
6.4 (4.5) 6.5 (4.7) 6.3 (4.3) 6.5 (4.7)and full randomization produced a higher percentage of women in the
resource priming condition. However, there was no indication that
this randomly produced unequal distribution was outcome-relevant
(p N 0.11 for all outcomes). Therapists were approximately 30 years
old on average and were all Swiss-German-speaking female psycholo-
gists with considerable knowledge and practice on conducting psycho-
therapies under RCT conditions (see Table 1).
Therapists reported that the preparation of the style-sheets at the
beginning of the therapies took 29min on average (SD=20.9). The sin-
gle primings were conducted by face-to-face or phone contact and took
10.2 min on average (SD= 6.25). A total of 84.4% of the primings were
conducted in the peer-format, and 16.5% were conducted by the thera-
pists themselves (because of a conﬂicting schedule of the peer-partner).
The means of the outcomes measures at pre-, intermediate, post-
assessment and follow-up assessments and the pre-post effect sizes
are presented at Table 2.
3.1. Treatment Efﬁcacy From Intake to Follow-up Assessment
The results of the hierarchical linear model from the outcome com-
posite are presented at Table 3 (for the results of the single outcome
measures seeAppendix II). Full randomization selected slightly less bur-
dened patients for the adherence priming condition at intake (β00);
however, these differences were not statistical signiﬁcant. The model
indicated a signiﬁcant linear and quadratic growth (β10/β20)
representing a U-shaped curve of symptom reduction over time for all
three conditions. However, there were medium linear (β11) and qua-
dratic (β21) differences in symptom reductions in favor of both resource
priming conditions in comparison with the adherence priming condi-
tion, indicating faster symptom reduction within the two resource
priming conditions (see Fig. 2). During the course of the study, no seri-
ous adverse event (SAE) such as death or attempted suicide was
registered.
3.2. Observer Ratings (CTS-G)
The means of the observer ratings of the 100 video-analyzed ses-
sions are presented in Table 4. On a scale from “0” to “6”, themean com-
petences over the conditions were evaluated at about a “4” (therapist
applies a sufﬁcient range of methods with skill and ﬂexibility, enabling
the patient to develop new perspectives), with a range from “2” (thera-
pist applies either insufﬁcient or inappropriate methods, and/or with
limited skill and ﬂexibility) to “6” (excellent range and application, or
successful application in the face of difﬁculties). Themultivariate analy-
ses indicated differences between the three priming conditions (Pillai's
Trace: F [6/42] = 21.0, p = 0.001, ηp2 = 0.76). As expected, both re-
source priming conditions revealed higher scores in the resource activa-
tion item in comparison with the adherence priming condition (F[2/
22] = 10.8; p = 0.001; ηp2 = 0.50). Furthermore, the resource priming
condition indicated higher session-structuring (F[2/22] = 5.5; p =
0.01, ηp2 = 0.33) and general therapeutic competence (F[2/22] = 7.6;
p = 0.003, ηp2 = 0.41) in comparison with the supportive resource
and the adherence priming conditions. Zero-order correlations between
the observer ratings and the outcome composite at post-assessment re-
vealed the following: Resource activation: r= 0.11; session-structuring
competence: r = 0.04; general therapeutic competence: r = 0.00 (for
all p = n.s.).
4. Discussion
The results of the planed analysis corroborate the hypothesis that
implementation strategies may impact the treatment efﬁcacy of
evidence-based treatment in GAD. The present implementation study
indicated that both resource priming conditions lead to a faster reduc-
tion of symptom-related outcomes in comparison with the adherence
priming condition apparent at the post-assessments. Based on the in-
Table 2
Descriptives of the outcome measures.
Adherence priming Resource priming Supportive resource
priming
Pre–post ESΔ1
Measures n M (SD) n M (SD) n M (SD) 1.–2. 1.–3. 2.–3.
Disorder speciﬁc outcomes
BAI
Intake 19 23.4 (11.6) 19 24.4 (12.3) 19 22.7 (9.4)
Intermed 17 17.1 (10.5) 19 13.8 (9.1) 17 11.3 (5.6)
Post 14 14.8 (9.6) 18 11.8 (9.1) 17 9.9 (5.8) −0.43 −0.53 −0.03
Follow-up 15 13.0 (10.4) 16 9.4 (8.4) 14 13.7 (10.1)
PSWQ
Intake 19 63.2 (7.2) 19 65.4 (7.8) 19 63.7 (7.0)
Intermed 17 59.8 (5.8) 19 58.3 (8.8) 17 55.8 (8.7)
Post 14 55.0 (8.2) 18 53.0 (11.4) 17 51.2 (7.8) −0.42 −0.54 −0.01
Follow-up 15 52.6 (8.1) 16 50.9 (12.5) 14 50.4 (7.0)
Secondary outcomes
BDI-II
Intake 19 16.9 (8.0) 19 22.7 (10.1) 19 21.4 (10.3)
Intermed 17 14.4 (10.5) 19 13.7 (8.2) 17 15.6 (8.3)
Post 14 10.6 (8.8) 18 11.7 (10.5) 17 10.2 (5.5) −0.49 −0.67 −0.02
Follow-up SCL-9 15 8.7 (5.4) 16 7.5 (7.5) 14 10.8 (6.8)
Intake 19 14.3 (7.5) 19 16.4 (6.7) 19 17.9 (6.7)
Intermed 17 13.5 (6.5) 19 11.2 (5.5) 17 11.3 (5.1)
Post 14 10.1 (6.7) 18 8.8 (6.6) 17 8.9 (5.1) −0.51 −0.81 −0.24
Follow-up 15 7.0 (4.9) 16 8.0 (7.3) 14 8.5 (4.9)
RES2
Intake 19 116.5 (22.0) 19 107.7 (31.8) 19 112.0 (33.0)
Intermed 17 123.3 (24.6) 19 129.9 (32.9) 17 126.3 (29.6)
Post 14 140.0 (20.6) 18 144.5 (39.7) 17 144.5 (29.5) −0.42 −0.35 0.12
Follow-up 15 125.7 (31.6) 16 144.7 (34.2) 14 130.4 (27.5)
Outcome composite3
Intake 19 55.2 (8.2) 19 58.3 (10.3) 19 57.7 (9.1)
Intermed 17 51.9 (8.3) 19 49.6 (8.8) 17 48.9 (7.9)
Post 14 47.8 (8.9) 18 45.5 (11.4) 17 45.1 (6.0) −0.53 −0.69 −0.02
Follow-up 15 45.3 (7.2) 16 43.9 (10.7) 14 45.8 (8.8)
Legend. BAI = Beck Anxiety Inventory, PSWQ = Penn State Worry Questionnaire, BDI = Beck Depression Inventory II, SCL = Symptom Check List 9, RES = Resource Self-report Ques-
tionnaire. Intake = intake assessment, Intermed= intermediate assessment at week 6, post = post-assessment at week 14, Follow-up = 6-month follow-up.
1. = adherence priming, 2. = resource priming, 3. = supportive resource priming.
1 = Relative effect sizes (ESΔ) from intake to post-assessment; adherence priming is reference group; ES of RES is reversed.
2 = higher scores represent more resources.
3 = Standardized composite of symptom reduction of all 5 self-report questionnaires.
Table 3
Growth model from intake to 6-month follow-up assessment.
Outcome composite
Coeff (SE) t-Ratio
Fixed part
For intake
Base (β00) 57.6 (2.0)
Adherence priming (β01) −2.3 (2.7) 0.9
Resource priming (β02) 0.4 (3.0) 0.1
For linear growth
Base (β10) −33.4 (6.9) 4.9⁎⁎⁎
Adherence priming (β11) 19.9 (8.9) 2.2⁎
Resource priming (β12) 5.1 (10.2) 0.5
For quadratic growth
Base (β20) 21.4 (6.7) 3.2⁎⁎
Adherence priming (β21) −17.0 (8.6) 2.2⁎
Resource priming (β22) −6.4 (9.0) 0.7
Random part
Level 2 intercept (r0j) 45.5
Level 2 linear growth (r1j) 18.9
Level 1 (etj) 28.5
dfs for t-ratio = 54; 194.
Outcome composite of symptom reduction based on BAI, PSWQ, BDI-II, SCL-9, and RES.
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
168 C. Flückiger et al. / EBioMedicine 3 (2016) 163–171session observer ratings, both resource priming conditions indicated
higher strengths-orientation (“resource activation”) in comparison
with the adherence priming condition. The implementation of an
evidence-based treatment is largely principle-based, allowing consider-
able therapeutic ﬂexibility in the determination and timing of different
treatment aspects (Norcross, 2011; Cheavens et al., 2012; Castonguay &
Beutler, 2006). Therefore, therapists using these treatments must make
decisions about these different treatment aspects.
There are several theoretical considerations that might or might not
explain these efﬁcacy differences alone or in combination with each
other. As a ﬁnal common pathway, individuals who suffer from GAD
might show restrictions in proactive behaviors as they become focused
on avoiding events rather than approaching activities with personal
values. The capitalization model might sensitize the therapists for pro-
ductive proactive patient behaviors in generalized anxiety (Roemer
et al., 2005; Flückiger et al., 2013) and also in humans more generally
(Bohart & Tallman, 1999; Padesky & Mooney, 2012); and vice versa,
the adherence priming condition might tend to make therapists main-
tain the restricted focus on avoiding negative events (e.g., get out of
GAD) and rigid information processing (Newman & Llera, 2011).
Interestingly, the resource priming condition indicated higher in-
session and general therapeutic competences in comparison with the
supportive priming condition and the adherence priming condition. Al-
thoughmeta-analytic ﬁndings and our study results do not support that
the general a priori deﬁned (cognitive behavioral) therapist compe-
tences are generally correlated with treatment outcomes (Webb et al.,
2010), our results indicate a somewhat paradoxical picture that thera-
pists who were straightforwardly focused on a common strategy toget competent adherence to the treatment protocol did not achieve
higher competence scores than those therapists who did not have
such an explicit focus. Nonetheless, these ﬁndings are in line with the
Fig. 2.Growthmodels of symptom reduction from intake to follow-up assessment. Legend:M=50, SD=10; standardized outcome composite of 5 self-report questionnaires BAI, PSWQ,
BDI-II, SCL-9, and RES.
169C. Flückiger et al. / EBioMedicine 3 (2016) 163–171results that therapists' adherence ﬂexibility (Owen & Hilsenroth, 2014)
and further aspects of therapists' ﬂexibility in general might impact
therapist-patient in-session interactions as well as treatment outcomes
(Wampold & Imel, 2014; Ackerman & Hilsenroth, 2003; Grawe, 2006).
In designing the present study, we considered possible alternative
explanations for potential efﬁcacy differences: First, patient preferences.
In human treatments where patients and treatment providers closely
work together, patients might have preferences for a certain treatment
protocol (such as e.g. a psychodynamic or a cognitive behavioral thera-
py) and therefore might explicitly contact a specialized provider. Pa-
tients are usually informed about the speciﬁc treatment approach or
modality and are therefore able to detect the speciﬁed randomized con-
dition of their treatment (e.g., group vs. single setting; treatment tradi-
tion). Because this trial did not contrast distinctive overall treatment
protocols, patients were not informed about any randomization proce-
dure at any stage of the study implementation. However, the patients
were informed about the overall treatment protocol (MAW-packet),
and within this packet, the patient's preferences for speciﬁc interven-
tions and procedures might well be a careful advisement in all three
priming conditions. Second, therapists' preferences. Therapists were re-
cruited to learn a speciﬁc treatment protocol of a neglected disorder in
the mental health system (GAD). At the recruitment, they were not in-
formed about themajor research interest in the three randomized prim-
ing conditions. However, as in many randomized clinical intervention
studies, therapists were not randomized for the conditions, and the
therapists' preferences for committing to a priming partner, a priming
condition and the supervisorswere taken into account. In the adherence
of priming condition there was a peer dyad that had no preference to a
speciﬁc priming condition, which resulted in concerns from the re-
search team that these therapistsmight tend to be slightlymore ﬂexible
or alternatively less allegiant to this condition. However, therapists'Table 4
In-session competence ratings.
CTS-G Adherence priming Resourc
M (SD) M (SD)
Resource activation 4.0 (0.09) 4.6 (0.09
Session-structuring comp. 3.9 (0.09) 4.3 (0.09
General therapeutic comp. 4.0 (0.07) 4.3 (0.07
1. = adherence priming, 2. = resource priming, 3. = supportive resource priming, CTS-G = C
1 = Tukey.
n = 100 sessions.preferences for emphasizing a speciﬁc intervention component such
as in vivo situational exposure or cognitive restructuring within the
MAW-packet might bewell considered in all three conditions. Third, re-
searcher allegiance. Researcher's interests might impact the perfor-
mance of therapists and the study conduction more generally, for
example, the therapists might have believed that the supportive re-
source priming condition was preferred by the research team (e.g. GB
as CBT-couple therapist and head of the department where this trial
was conducted) and therefore had extraordinary engagement in this
condition. However,when arranging the research team, the three senior
researchers had three different theoretical backgrounds and were
themselves divided in their predictions, with each having contrary ex-
pectations about the relative efﬁcacy of the three conditions. Further-
more, the design of three treatment arms was selected to enable study
replication for potential effects in favor of capitalization models. None-
theless, researcher allegiance may have impacted the present study re-
sults even though the authors intended to minimize such effects
(Wampold & Imel, 2014).
There are several substantial limitations that merit consideration.
First, the careful selection process of individuals who suffer from GAD
limited the sample size, as is a common phenomenon in all randomized
clinical trials on GAD. Themeta-analysis of Hanrahan, for example, indi-
cated a mean intent-to-treat sample size of 48 participants for each
study. Second, the study enrolment might have tended to select well-
educated individuals who suffer from GAD. Although the comorbidity
rates and the prior psychotherapies indicate lasting distress and suffer-
ing in these individuals, this study populationmight also tend to bewell
skilled in other functional areas. It might be true that the individuals in
this populationwere especially encouraged and attracted by the capital-
ization model. Third, the (on average) 30-year-old female therapists
with considerable experience in participating in randomized controllede priming Supportive resource priming Posthoc1
M (SD)
) 4.4 (0.08) 1. b 2. = 3.
) 3.9 (0.08) 1. = 3. b 2.
) 4.1 (0.06) 1. = 3. b 2.
ognitive Therapy Scale — German version.
170 C. Flückiger et al. / EBioMedicine 3 (2016) 163–171trials were highly intrinsically motivated to learn the present treatment
protocol initiated, e.g., by the initial workshop. This might limit the gen-
eralizability of the present implementation study to settings with less
dedicated therapists. Forth, because the individuals that suffer from
GAD probably are the most direct source of information to evaluate
their worrying, the outcomes were assessed by self-report measures.
However, other sources of information e.g. rated by observer might
provide a broader picture of treatment outcomes. Fifth, the observer-
ratings were focused on competence ratings of selected sessions. More
comprehensive analyses of all sessions may provide a much more pre-
cise picture of competence and adherence ratings over the whole
therapy.
Clearly, before further replications, the present promising but pre-
liminary data should be interpreted cautiously.
Beyond replication, future research with larger samples of patients
as well as therapists might examinemore precise pathways along com-
mon processes throughwhich the capitalizationmodelmay outperform
the compensation model. For example, therapists' dedicated engage-
ment in a therapy and/or a patient might represent a shared aspect of
capitalization models and therapist/researcher allegiance concepts
(Wampold & Imel, 2014). Furthermore, future trials should not only
be designed to investigate priming effects between conditions, but
should also be designed to investigate potential priming effects within
therapists using crossed-therapist designs (Baldwin & Imel, 2013). In
respect to patient populations, capitalization and compensationmodels
should be tested in other populations to examine if and how the pa-
tients might beneﬁt from or be harmed by capitalization models
(Wingate et al., 2005). The present trial shows the promise of theoreti-
cally driven systematic strategies of how to implement an overall treat-
ment packet. It highlights the empirically slightly disregarded practical
issue of “how to implement” rather than “what to implement” under
rigorous randomized controlled study conditions.Contributors
CF, RZ andGB designed the trial. CF was funded by the Swiss Nation-
al Science Foundation (SNSF) and had themain lead in the trial. RZ pro-
vided the CBT training for the trial therapists and research workers. IB,
LF, and BS conducted the data collection. CF, LF, and BS conducted the
analyses of the trial outcomes and observer ratings. CF took responsibil-
ity for drafting the study report. All authors contributed to reading and
correcting the study report and approved the ﬁnal report. We thank all
of the participants and therapists for their engagement in the trial.Declaration of Interests
We declare no competing interests.Role of the Funding Source
The Swiss National Science Foundation (SNSF) granted the study,
reviewed the application for the trial and monitored the progress of
trial milestones (e.g., recruitment progress). The funder had no role in
the study design, data collection, data analysis, data interpretation, or
writing of the report. The corresponding author had full access to all of
the data in the study and had ﬁnal responsibility for the decision to sub-
mit for publication.Appendix. Supplementary Data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2015.11.049.References
Ackerman, S.J., Hilsenroth, M.J., 2003. A review of therapist characteristics and techniques
positively impacting the therapeutic alliance. Clin. Psychol. Rev. 23, 1–33.
Baldwin, S.A., Imel, Z.E., 2013. Therapist effects: ﬁndings and methods. In: Lambert, M.J.
(Ed.), Bergin and Garﬁeld's Handbook of Psychotherapy and Behavior Change.
Wiley, Hoboken, NJ.
Barlow, D.H., Rapee, R.M., Brown, T.A., 1992. Behavioral treatment of generalized anxiety
disorder. Behav. Ther. 23 (4), 551–570.
Beck, A.T., Steer, R.A., K. BG., 1996. BDI-II, Beck Depression Inventory. Harcourt, MA,
Boston.
Beck, A.T., Epstein, N., Brown, G., Steer, R.A., 1988. An inventory for measuring clinical
anxiety: psychometric properties. J. Consult. Clin. Psychol. 56, 893–897.
Bohart, A.C., Tallman, K., 1999. How clients make therapy work the process of active self-
healing XVI. American Psychological Association, Washington, DC (347 S. pp.).
Borkovec, T.D., Alcaine, O., Behar, E.S., 2004. Avoidance theory of worry and generalized
anxiety disorder. In: Heimberg, R., Mennin, D., Turk, C. (Eds.), Generalized Anxiety
Disorder: Advances in Research and Practice. Guilford, New York, NY, pp. 77–108.
Castonguay, L.G., Beutler, L.E., 2006. Principles of therapeutic change: a task force on par-
ticipants, relationships, and techniques factors. J. Clin. Psychol. 62, 631–638.
Cheavens, J.S., Strunk, D.R., Lazarus, S.A., Goldstein, L.A., 2012. The compensation and cap-
italization models: a test of two approaches to individualizing the treatment of de-
pression. Behav. Res. Ther. 50 (11), 699–706.
Craske, M.G., Barlow, D.H., 2006. Mastery of Your Anxiety and Worry — Workbook. Ox-
ford University Press, New York, NY.
Cuijers, P., Sijbradij, M., Koole, S., Huibers, M., Berking, M., Andersson, G., 2014. Psycholog-
ical treatment of generalized anxiety disorder: a meta analysis. Clin. Psychol. Rev. 34,
130–140.
Flückiger, C., Grosse Holtforth, M., 2008. Focusing the therapist's attention on the patient's
strengths: a preliminary study to foster a mechanism of change in outpatient psycho-
therapy. J. Clin. Psychol. 64 (7), 876–890.
Flückiger, C., Del Re, A.C., Munder, T., Heer, S., Wampold, B.E., 2014. nduring effects of
evidence-based psychotherapies in acute depression and anxiety versus treatment
as usual at follow-up — a longitudinal meta-analysis. Clin. Psychol. Rev. 34, 367–375.
Flückiger, C., Wüsten, G., Zinbarg, R.E., Wampold, B.E., 2010. Resource Activation — Using
Clients' Own Strengths in Psychotherapy and Counseling. Hogrefe, Cambridge, MA.
Flückiger, C., Zinbarg, R.E., Znoj, H., Ackert, M., 2013. Resource activation in generalized
anxiety—an observer-based microprocess analysis of patients' in-session outcomes.
Psychotherapy 51, 535–545.
Flückiger, C., 2014. The adherence/resource priming paradigm — a randomised clinical
trail conducting a bonaﬁde psychothearpy protocol for generalised anxiety disorder.
BMC Psychiatry. 14, 49.
Gassmann, D., Grawe, K., 2006. General change mechanisms: the relation between prob-
lem activation and resource activation in successful and unsuccessful therapeutic in-
teractions. Clin. Psychol. Psychother. 13 (1), 1–11.
Grawe, K., 2006. Neuropsychotherapy. Lawrence Erlbaum, Hillsdale, NJ.
Hanrahan, F., Field, A.P., Jones, G.W., Davey, G.C.L., 2013. Ameta-analysis of cognitive ther-
apy for worry in generalized anxiety disorder. Clin. Psychol. Rev. 33, 120–132.
Klaghofer, R., Brähler, E., 2001. Konstruktion und Teststatistische Prüfung einer Kurzform
der SCL-90-R (Construction and test statistical evaluation of a short version of the
SCL-90-R). Z. Klin. Psychol. Psychiatr. Psychother. 49, 115–124.
Lieb, R., Becker, E., Altamura, C., 2005. The epidemiology of generalized anxiety disorder in
Europe. Eur. Neuropsychopharmacol. 15 (4), 445–452.
Margraf, J., Schneider, S., Ehlers, A., 1991. Diagnostisches Interview bei Psychischen
Störungen (DIPS). Springer, Berlin, Germany.
Mennin, D.S., McLaughlin, K.A., Flanagan, T.J., 2009. Emotion regulation deﬁcits in gener-
alized anxiety disorder, social anxiety disorder, and their co-occurrence. J. Anxiety
Disord. 23 (7), 866–871.
Meyer, T.J., Miller, M.L., Metzger, R.L., D. BT, 1990. Development and validation of the Penn
State Worry Questionnaire. Behav. Res. Ther. 28, 487–495.
Michelson, S.E., Lee, J.K., Orsillo, S.M., Roemer, L., 2011. The role of values-consistent be-
havior in generalized anxiety disorder. Depress. Anxiety 28 (5), 358–366.
Morris, S.B., 2008. Estimating effect sizes from pretest-posttest-control group designs.
Organ. Res. Methods 11, 364–386.
Newman, M.G., Llera, S.J., 2011. A novel theory of experiential avoidance in generalized
anxiety disorder: a review and synthesis of research supporting a contrast avoidance
model of worry. Clin. Psychol. Rev. 31 (3), 371–382.
Norcross, J.C., 2011. Psychotherapy Relationships ThatWork: Evidence-based Responsive-
ness. 2nd ed. Oxford University Press, New York, NY.
Owen, J., Hilsenroth, M.J., 2014. Treatment adherence: the importance of therapist ﬂexi-
bility in relation to therapy outcomes. J. Couns. Psychol. 61, 280–288.
Padesky, C.A., Mooney, K.A., 2012. Strengths-based cognitive-behavioural thera-
py: a four-step model to build resilience. Clin. Psychol. Psychother. 19 (4),
283–290.
Roemer, L., Salters, K., Raffa, S., Orsillo, S., 2005. Fear and avoidance of internal experiences
in GAD: preliminary tests of a conceptual model. Cogn. Ther. Res. 29 (1), 71–88.
Rosenhan, D., 1984. In: Watzlawick, P. (Ed.), On Being Sane in Insane Places. Norton, New
York, NY.
Scheel, M.J., Davis, C.K., Hederson, J.D., 2013. Therapist use of client strengths: a qualita-
tive study of positve processes. Couns. Psychol. 41, 392–427.
Troesken, A., Grawe, K., 2004. Ressourcenpotential und — realisierung für Psychologische
Therapie. Verhaltensther. Psych. Prax. 36, 51–62.
Wampold, B.E., Imel, Z.E., 2014. The Great Psychotherapy Debate — The Evidence for
What Makes Psychotherapy Work. Routledge, New York, NY.
Webb, C.A., DeRubeis, R.J., P. BJ, 2010. Therapist adherence/competence and treatment
outcome: a meta-analytic review. J. Consult. Clin. Psychol. 78, 200–211.
171C. Flückiger et al. / EBioMedicine 3 (2016) 163–171Weck, F., Hautzinger, M., Heidenreich, T., Stangier, U., 2010. Erfassung
psychotherapeutischer Kompetenzen (German version of the CTS). Z. Klin. Psychol.
Psychother. 39, 244–250.
Whisman, M.A., 2008. Adapting Cognitive Therapy for Depression: Managing Complexity
and Comorbidity. Guilford Press, New York, NY.
Wingate, L.R., Van Orden, K.A., Joiner, T.E., Williams, F.M., Rudd, M.D., 2005. Comparision
of compensation and capitalization models when treating suicidality in young adults.
J. Consult. Clin. Psychol. 73, 756–762.
Wittchen, H.-U., Zaudig, M., Fydrich, T., 1997. SKID. Strukturiertes Klinisches Interview für
DSM-IV Achse I und II Handanweisung. Hogrefe, Göttingen, Germany.Zinbarg, R.E., Craske, M.G., Barlow, D.H., 2006. Mastery of Your Anxiety and Worry
(MAW): therapist guide. Therapist Guide. Oxford University Press.
Zinbarg, R.E., Lee, J.E., Yoon, L., 2007. Dyadic predictors of outcome in a cognitive-
behavioral program for patients with generalized anxiety disorder in committed
relationships: a ‘spoonful of sugar’ and a dose of non-hostile criticism may help.
Behav. Ther. 45, 699–713.
